Abstract:Bangladesh has achieved significant progress towards malaria elimination, although health service delivery for malaria remains challenging in remote forested areas such as the Chittagong Hill Tracts (CHT). The aim of this study was to investigate perceptions of malaria and its treatment among the local population to inform contextualized strategies for rolling out radical cure for P. vivax in Bangladesh. The study comprised two sequential strands whereby the preliminary results of a qualitative strand informed… Show more
“…To assess the feasibility of implementing the biosensor in Bangladesh from the perspective of various users, a qualitative research study was undertaken to investigate user perspectives and practices of G6PD diagnostics [ 27 , 28 ]. However, considerations around specific treatment courses and P. vivax case management as a whole were beyond the scope of the study, but have been the focus of another recent study [ 29 ]. This paper reports the different considerations and practices at clinic, health worker and policy levels that influence the introduction ofG6PD diagnostics for new radical cure therapeutics.…”
Background
The radical cure of Plasmodium vivax requires treatment with an 8-aminoquinoline drug, such as primaquine and tafenoquine, to eradicate liver hypnozoite stages, which can reactivate to cause relapsing infections. Safe treatment regimens require prior screening of patients for glucose-6-phosphate dehydrogenase (G6PD) deficiency to avoid potential life-threatening drug induced haemolysis. Testing is rarely available in malaria endemic countries, but will be needed to support routine use of radical cure. This study investigates end-user perspectives in Bangladesh on the introduction of a quantitative G6PD test (SD Biosensor STANDARD™ G6PD analyser) to support malaria elimination.
Methods
The perspectives of users on the SD Biosensor test were analysed using semi-structured interviews and focus group discussions with health care providers and malaria programme officers in Bangladesh. Key emerging themes regarding the feasibility of introducing this test into routine practice, including perceived barriers, were analysed.
Results
In total 63 participants were interviewed. Participants emphasized the life-saving potential of the biosensor, but raised concerns including the impact of limited staff time, high workload and some technical aspects of the device. Participants highlighted that there are both too few and too many P. vivax patients to implement G6PD testing owing to challenges of funding, workload and complex testing infrastructure. Implementing the biosensor would require flexibility and improvisation to deal with remote sites, overcoming a low index of suspicion and mutual interplay of declining patient numbers and reluctance to test. This approach would generate new forms of evidence to justify introduction in policy and carefully consider questions of deployment given declining patient numbers.
Conclusions
The results of the study show that, in an elimination context, the importance of malaria needs to be maintained for both policy makers and the affected communities, in this case by ensuring P. vivax, PQ treatment, and G6PD deficiency remain visible. Availability of new technologies, such as the biosensor, will fuel ongoing debates about priorities for allocating resources that must be adapted to a constantly evolving target. Technical and logistical concerns regarding the biosensor should be addressed by future product designs, adequate training, strengthened supply chains, and careful planning of communication, advocacy and staff interactions at all health system levels.
“…To assess the feasibility of implementing the biosensor in Bangladesh from the perspective of various users, a qualitative research study was undertaken to investigate user perspectives and practices of G6PD diagnostics [ 27 , 28 ]. However, considerations around specific treatment courses and P. vivax case management as a whole were beyond the scope of the study, but have been the focus of another recent study [ 29 ]. This paper reports the different considerations and practices at clinic, health worker and policy levels that influence the introduction ofG6PD diagnostics for new radical cure therapeutics.…”
Background
The radical cure of Plasmodium vivax requires treatment with an 8-aminoquinoline drug, such as primaquine and tafenoquine, to eradicate liver hypnozoite stages, which can reactivate to cause relapsing infections. Safe treatment regimens require prior screening of patients for glucose-6-phosphate dehydrogenase (G6PD) deficiency to avoid potential life-threatening drug induced haemolysis. Testing is rarely available in malaria endemic countries, but will be needed to support routine use of radical cure. This study investigates end-user perspectives in Bangladesh on the introduction of a quantitative G6PD test (SD Biosensor STANDARD™ G6PD analyser) to support malaria elimination.
Methods
The perspectives of users on the SD Biosensor test were analysed using semi-structured interviews and focus group discussions with health care providers and malaria programme officers in Bangladesh. Key emerging themes regarding the feasibility of introducing this test into routine practice, including perceived barriers, were analysed.
Results
In total 63 participants were interviewed. Participants emphasized the life-saving potential of the biosensor, but raised concerns including the impact of limited staff time, high workload and some technical aspects of the device. Participants highlighted that there are both too few and too many P. vivax patients to implement G6PD testing owing to challenges of funding, workload and complex testing infrastructure. Implementing the biosensor would require flexibility and improvisation to deal with remote sites, overcoming a low index of suspicion and mutual interplay of declining patient numbers and reluctance to test. This approach would generate new forms of evidence to justify introduction in policy and carefully consider questions of deployment given declining patient numbers.
Conclusions
The results of the study show that, in an elimination context, the importance of malaria needs to be maintained for both policy makers and the affected communities, in this case by ensuring P. vivax, PQ treatment, and G6PD deficiency remain visible. Availability of new technologies, such as the biosensor, will fuel ongoing debates about priorities for allocating resources that must be adapted to a constantly evolving target. Technical and logistical concerns regarding the biosensor should be addressed by future product designs, adequate training, strengthened supply chains, and careful planning of communication, advocacy and staff interactions at all health system levels.
“…The Bangladeshi context was initiated through a combination of published literature in Bangladesh, insights from informal conversations with malaria elimination experts from NMEP and BRAC, and focus group discussions with private healthcare Providers. [3][4][5][6][7]20 RESULTS.…”
Section: Methodsmentioning
confidence: 99%
“…These districts also feature a high proportion of remote communities of isolated, Indigenous (non-Bengali) peoples, presenting cultural practices that compound geographical barriers to prevent access for malaria elimination programs. 4,5 In contrast, two low-endemic districts, Cox’s Bazar and Chittagong, are more accessible to present control efforts. These regions plan to eliminate the endogenous transmission within the districts by 2025, but will continue to face the prospect of imported malaria due to high levels of human travel from the neighboring high-transmission CHT districts until the 2030 elimination date.…”
Bangladesh reduced malaria by 93% from 2008-2020 through the action of governmental and non-governmental organizations, yet ∼18 million people continue to live at risk of infection. For-profit private healthcare providers, catalytic for malaria elimination in many countries, have not yet been integrated into the national program. By imposing strict definitions on a large and complex literature surrounding private healthcare sector engagement, we distilled eight distinct strategies important in other developing settings: contracting, financing, subsidization, regulation, social franchising, demand-side interventions, infrastructure-building and training. We weighed these in the context of Bangladesh’s flourishing private health care sector—driven by patient demand, self-interest, and aspirations for public good—as well as the heterogeneity in provider capacity and malaria prevalence across districts. We developed a new model dependent on five strategies of subsidization, training, infrastructure building, demand-side intervention, and referral financing, to empower Bangladesh’s phased agenda of eliminating indigenous malaria transmission by 2030.
“…However, patients must pay for services and drugs provided at private clinics, pharmacies, and, to some extent, public hospitals; it is unlikely that many participants would prefer this option over free treatment delivered at home as part of the DSS. A subset of 100 participants from each case and control arm were included in a separate study of the perceptions of malaria [47]. A total of 6 participants from the control arm recalled having had malaria previously, whereas only 1 case could not recall any previous episodes of malaria.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.